Wang J.;Ju B.;He L.;
<正>Objective: Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis(RA). Altered B cell subsets have been reported in RA patients pathology. This study was undertaken to evaluate the effects of tofacitinib on B memory subsets in RA patients.
Evaluation of tofacitinib on B cell subsets in patients with rheumatoid arthritis;
To explore the background and basis of the node document